A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol/drospirenone regimens in healthy young female volunteers over a period of 3 treatment cycles.

Trial Profile

A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol/drospirenone regimens in healthy young female volunteers over a period of 3 treatment cycles.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Jun 2014

At a glance

  • Drugs Estradiol/drospirenone (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 30 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Sep 2008 Bayer Schering Pharma added as an affiliate as reported by ClinicalTrials.gov.
    • 24 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top